Chronic Myelomonocytic Leukemia-1
5 clinical trials · Condition
◉ Watch Chronic Myelomonocytic Leukemia-1
| Record | Firm | Date |
|---|---|---|
| Phase I/II Study of Tagraxofusp in Combination With Decitabine for Patients With Myelomonocytic/Myeloproliferative Neoplasm and High Risk Myelodysplastic Syndromes (NCT05038592) | M.D. Anderson Cancer Center | 2022-03-04 |
| Seclidemstat and Azacitidine for the Treatment of Myelodysplastic Syndrome or Chronic Myelomonocytic Leukemia (NCT04734990) | M.D. Anderson Cancer Center | 2021-07-07 |
| Azacitidine With or Without Lenalidomide or Vorinostat in Treating Patients With Higher-Risk Myelodysplastic Syndromes or Chronic Myelomonocytic Leukemia (NCT01522976) | National Cancer Institute (NCI) | 2012-03-01 |
Track Chronic Myelomonocytic Leukemia-1 automatically
Every clearance here is in the API, with alerts when new ones post.